Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial

OBJECTIVES: To report 4-year imaging outcomes in the RAPID-axSpA (NCT01087762) study of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA), treated with certolizumab pegol (CZP). METHODS: This phase III, randomised trial was placebo-controlled and doubl...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Heijde, Désirée, Baraliakos, Xenofon, Hermann, Kay-Geert A, Landewé, Robert B M, Machado, Pedro M, Maksymowych, Walter P, Davies, Owen R, de Peyrecave, Natasha, Hoepken, Bengt, Bauer, Lars, Nurminen, Tommi, Braun, Juergen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909752/
https://www.ncbi.nlm.nih.gov/pubmed/29343510
http://dx.doi.org/10.1136/annrheumdis-2017-212377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909752/
https://www.ncbi.nlm.nih.gov/pubmed/29343510
http://dx.doi.org/10.1136/annrheumdis-2017-212377

Ejemplares similares